Contact Person
David Munis Zepernick

Head of Business Development and Public Affairs

Phone: (M) +45 2498 1668


Below you will find the latest news from MVA. You can also sign up to our newsletter MVA Update.

MVA Update is an electronic newsletter providing you with news about MVA and an overview of our events and other relevant events in Medicon Valley. You can also check out our calendar for more information about life science events in the region.

If you have any questions regarding our news section or media inquiries then please contact David Munis Zepernick, Head of Press on +45 2498 1668.

26 Sep

Well-attended Synapse Life Science Career Fair at the The Maersk Tower, University of Copenhagen

September 25th,the student-driven organisation Synapse – Life Science Connect, that creates events, workshops, and networking opportunities for students and young professionals with an interest in pursuing careers in the life science industry hosted a very succesful career fair indicating a

20 Sep

MVA-member company, Genmab, presents new data on next-generation treatments for multiple sclerosis

In Stockholm, Sweden, the The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) recently gathered experts and companies working on multiple sclerosis.  Among the presenters were the Danish antibody developer Genmab, which presented results from its drug ofatumumab,

10 Sep

MVA-member, BioInnovation Institute, will award an extra DKK 35M to start-ups joining their Creation House program

There is good news for early-stage Nordic start-ups in medtech, biotech and pharma. In 2019, BioInnovation Institute will award an extra DKK 35M which will amount to a total of DKK 150M awarded to life science projects since the inauguration

06 Sep

Copenhagen named among most liveable cities in the world

In the recently published index, published by Economist Intelligence Unit, Copenhagen scored 96.8 out of 100 thanks to top scores (100) in Infrastructure and Education, while the city also achieved high scores (over 95) in the other categories: Stability, Healthcare

03 Sep

MVA Chairman of the Board, Dr. Søren Bregenholt, appointed new CEO of Macrophage Pharma

Macrophage Pharma Limited (‘MPL’), a company focused on the discovery and development of next-generation immunomodulatory small molecules inducing transcriptional reprofiling of macrophages to combat cancer and other diseases, announced today that it has appointed Dr Soren Bregenholt as Chief Executive

02 Sep

Last change to register for Nordic Life Science Days with your 20 % MVA-member discount

Nordic Life Science Days is the largest Nordic partnering conference dedicated to the life science industry. Since its inception in 2013, the event has nurtured a community of people from the world of life science, and created a unique place

16 Aug

Medicon Valley based life science start-up companies are encouraged to compete for the €100K Global Challenge Grand Prize

Applications for the 6th edition of the Global Challenge are now open! The organizers, Hello Tomorrow, have explicitly asked, if we would help them raise awareness of this opportunity among the many innovative life science start-up companies in Medicon Valley.

13 Aug

MVA CEO, Petter Hartman, was interviewed in the newsletter, Rapidus, about investment promotion and the new joint microbiome project with Copenhagen Capacity and Invest in Skåne

Back in the saddle after the summer break, MVA CEO Petter Hartman was interviewed by Rapidus journalist, Keld Broksø, about the recent joint microbiome project with Copenhagen Capacity and Invest in Skåne. Normally, a subscription is needed, but we were

02 Aug

“Leaving on a Jet plane” piece by MVA CEO, Petter Hartman, in Pharmaceutical Manufacturing and Packing Sourcer (PMPS)

What does the title of one of John Denver´s greatest hits has to do with  life science in Medicon Valley? well, as part of Medicon Valley Alliance´s involvement in the upcoming “FlyPharma Europe 2019 Conference” 22nd-23rd of October, MVA CEO,